Skip to content
value.today

Prescribe FIT, Inc.

🇺🇸 Columbus, Ohio, USAHealth CareFounded 2017
Total raised
$6 M
4 rounds on record
Latest round
$1 M
Oct 2025
First round on record
Jun 2022
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Prescribe FIT, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2025$1 MNo. 4Under $2 million

Prescribe FIT, Inc.: Raise no. 4, Oct 2025

Investors in this round

2 investors had bought by the notice of Oct 20, 2025: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$500,000
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brock Leonti · Executive Officer, Director
  • Jack Gainer · Executive Officer
  • Jane Grote Abell · Director
  • Joseph Anthony Capuano, Iii · Director
  • Mark Shary · Director
  • Michael C. Kauffmann · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general working capital purposes, including regular payment of executive salaries.”

Signed by Brock Leonti, Ceo. Newest notice filed Oct 20, 2025. Read the notice at the SEC.

equity, debtSEC
May 2024$2 MNo. 3Under $2 million

Prescribe FIT, Inc.: Raise no. 3, May 2024

Investors in this round

11 investors had bought by the notice of Jun 7, 2024: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brock Leonti · Executive Officer, Director
  • Jack C Gainer · Executive Officer
  • Jane Grote Abell · Director
  • Joseph A Capuano, III · Director
  • Mark A Shary · Director
  • Michael C Kaufmann · Director
  • Peter A Edwards, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general working capital, which may include salaries to officers in the ordinary course.”

Signed by Brock Leonti, Ceo. Newest notice filed Jun 7, 2024. Read the notice at the SEC.

equitySEC
Apr 2023$2 MNo. 2$2 to $10 million

Prescribe FIT, Inc.: Raise no. 2, Apr 2023

Investors in this round

13 investors had bought by the notice of Oct 30, 2023: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brock Leonti · Executive Officer, Director
  • Jack Gainer · Executive Officer
  • James Grote · Director
  • Mark Shary · Director
  • Michael C Kaufmann · Director
  • Peter Edwards, Jr. · Director
  • Thomas Grote · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general working capital, which may include salaries to officers in the ordinary course.”

Signed by Brock Leonti, Ceo. Newest notice filed Oct 30, 2023. Read the notice at the SEC.

equitySEC
Jun 2022$1 MNo. 1Under $2 million

Prescribe FIT, Inc.: Raise no. 1, Jun 2022

Investors in this round

2 investors had bought by the notice of Jun 30, 2022: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brock Leonti · Executive Officer, Director
  • Jack Gainer · Executive Officer
  • James Grote · Director
  • Peter Edwards Jr. · Director
  • Thomas Grote · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “EXECUTIVE OFFICERS MAY RECEIVE A PORTION OF THE PROCEEDS THROUGH THEIR REGULAR SALARIES”

Signed by Brock Leonti, Chief executive officer. Newest notice filed Jun 30, 2022. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Prescribe FIT, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2025).

    SEC Form D · Oct 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Prescribe FIT, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Prescribe FIT, Inc.
NameRoleNamed in
Brock LeontiExecutive officerOct 2025
Jack GainerExecutive officerOct 2025
Jack C GainerExecutive officerJun 2024
Brock LeontiDirectorOct 2025
Jane Grote AbellDirectorOct 2025
Joseph Anthony Capuano, IiiDirectorOct 2025
Mark SharyDirectorOct 2025
Michael C. KauffmannDirectorOct 2025
Joseph A Capuano, IIIDirectorJun 2024
Mark A SharyDirectorJun 2024
Michael C KaufmannDirectorJun 2024
Peter A Edwards, Jr.DirectorJun 2024
James GroteDirectorOct 2023
Peter Edwards, Jr.DirectorOct 2023
Thomas GroteDirectorOct 2023
Peter Edwards Jr.DirectorJun 2022